Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FASTs 17th Annual Global Science Summit
November 09, 2024 10:30 ET | Source: Ultragenyx Pharmaceutical Inc. Phase 1/2…
Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME
Two oral presentations and multiple posters on clinical andpreclinical-stage candidates to be…
Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
New data showed a correlation between the levels of neural cell adhesion…
Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
November 08, 2024 10:00 ET | Source: Medicenna Therapeutics Corp. MDNA113…
Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext…
FP Markets Secures Three Major Honours at the Inaugural Finance Magnates Annual Award Gala
SYDNEY, Nov. 4, 2024 /PRNewswire/ -- Australian-founded broker FP Markets further cemented its position…
FP Markets Secures Three Major Honours at the Inaugural Finance Magnates Annual Award Gala
SYDNEY, Nov. 4, 2024 /PRNewswire/ -- Australian-founded broker FP Markets further cemented its position…
Optimal Breathing Holds its Annual Black Friday Sale
FORT MILL, S.C., Nov. 02, 2024 (GLOBE NEWSWIRE) -- Optimal Breathing will…